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SERUM CERULOPLASMIN-BOUND COPPER AND NON-CERULO-
PLASMIN COPPER IN UNCOMPLICATED PSORIASIS*
MATTI KEKKI, M.D.t, PENTTI KOSKELO, M.D.t AND ALLAN LASSUS, M.D4
It has been demonstrated by Lipkin et al. (1)
that the copper content of blood serum of pa-
tients with psoriasis is on an average signifi-
cantly higher than that of control subjects. A
considerable overlap, however, is apparent in the
serum copper levels in normal subjects and psori-
atics. The elevated serum copper levels found in
psoriasis appear to be unaccompanied by quanti-
tative tissue copper alterations (2). It is known
that copper bound to ceruloplasmia accounts for
almost all the serum copper—except in patients
with Wilson's disease—so that the copper and
ceruloplasmin almost always vary in the same
direction and either one is a good index of the
other (3). We found serum ceruloplasmin to be
normal in patients with uncomplicated psoriasis
(4), differing with the reports mentioned above.
'We therefore sought to determine whether the
elevation of copper observed is due to the eleva-
tion of a copper fraction in serum which is not
bound to ceruloplasmin.
MATERIAL AND METHODS
The material consisted of 58 healthy ambula-
tory subjects and 65 patients with uncomplicated
psoriasis. The controls consisted of 27 men and 31
women, from 20 to 59 years, the mean age being
43 years. In the psoriasis group there were 29 men
and 36 women. The mean age was 34 years and
the range from 7 to 78 years.
Serum copper was determined spectrophoto-
metrically with bicyclohexaaoaeoxalyldihydraxone
according to Peterson and Bollier (5). All pre-
cautions were taken to minimize the risk of chem-
ical contamination. Serum ceruloplasmin deter-
minations were carried out by the colorimetric
enzymatic method of Ravin (6). Double deter-
minations were made in every instance in both
the copper and the ceruloplasmin analyses. The
ceruloplasmin-bound copper was calculated from
the serum ceruloplasmin values obtained by tak-
ing into consideration that one ceruloplasmin
molecule contains eight copper atoms and that its
molecular weight is 160,000 (7). The serum con-
tent of the non-ceruloplasmin copper was ob-
tained simply by subtracting the ceruloplasmin
copper from the total copper.
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RESULTS
The results are given in Table I and in the dia-
gram Figure 1. No difference was seen in the
mean serum ceruloplasmin content of the control
subjects and the psoriasis patients. The mean
total copper content was higher in the psoriasis
group than in the control group. In spite of con-
siderable overlapping the difference is statistically
significant (p < 0.001). A very clear difference
was seen in the non-ceruloplasmin copper content
between the psoriasis patients and control sub-
jects. The non-ceruloplasmin copper content in
the psoriasis patients was on an average more
than twofold that of the controls, the difference
being statistically highly significant (p < 0.001).
No correlation was found between the increased
copper contents and routine laboratory tests and
clinical condition.
COMMENTS
It is evident that the elevation of the serum
copper level in patients with uncomplicated psori-
asis is due to an increase in a non-eeruloplasmin
bound copper fraction. The methodological error
due to the indirect fractional determination of
the copper content may be relatively large in the
small non-ceruloplasmia copper fraction. How-
ever, this does not affect the results since the
methodological error is of the same magnitude in
both the control and the experimental series.
TABLE I
Serum ceruloplasmin copper and non-ceruloplasmin
cop per in 58 healthy subjects and 65 patients
with uncomplicated psOriasis
Results are stated in pg. per 100 ml.
Total
Copper
Cerolo-
plasmio
Copper
Non-Cerolo-
plasmin
Copper
Healthy subjects
Mean
Range
S.D.
Patients with pso-
riasis
Mean
Range
S.D.
137
89-197
51
165
117—239
31
118
77—158
17
119
75—211
24
19
0—45
12
45
4—90
22
160
250
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It is known that copper plays a role in the
keratinization process of the skin of certain ani-
mals and that copper causes a defect in keratin
formation (8). The role of copper in the incom-
plete keratinization process of psoriatic skin is not
known. It could be thought that the psoriatic skin
is not able to utilize copper in the keratinization
process and causes a change in the distribution of
non-ceruloplasmin copper between the intravas-
cular and extravascular compartments of the
body.
SUMMARY
Serum total copper, ceruloplasmin-bound cop-
per and non-ceruloplasmin copper were studied in
58 healthy persons and 65 patients with uncom-
plicated psoriasis. No difference was seen in the
ceruloplasmin-bound copper between the two Se-
ries. The serum non-ceruloplasmin copper was
significantly elevated in patients with psoriasis.
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Fie. 1. Total semm copper, ceruloplasmin copper and non-ceruloplasmin copper in healthy
persons and patients with uncomplicated psorlasis.
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